Target-mediated drug disposition model for drugs with N > 2 binding sites that bind to a target with one binding site
- 19 April 2024
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Pharmacodynamics
- Vol. 51 (6) , 703-720
Abstract
The paper extended the TMDD model to drugs with more than two (N > 2) identical binding sites (N-to-one TMDD). The quasi-steady-state (N-to-one QSS), quasi-equilibrium (N-to-one QE), irreversible binding (N-to-one IB), and Michaelis–Menten (N-to-one MM) approximations of the model were derived. To illustrate properties of new equations and approximations, N = 4 case was investigated numerically. Using simulations, the N-to-one QSS approximation was compared with the full N-to-one TMDD model. As expected, and similarly to the standard TMDD for monoclonal antibodies (mAb), N-to-one QSS predictions were nearly identical to N-to-one TMDD predictions, except for times of fast changes following initiation of dosing, when equilibrium has not yet been reached. Predictions for mAbs with soluble targets (slow elimination of the complex) were simulated from the full 4-to-one TMDD model and were fitted to the 4-to-one TMDD model and to its QSS approximation. It was demonstrated that the 4-to-one QSS model provided nearly identical description of not only the observed (simulated) total drug and total target concentrations, but also unobserved concentrations of the free drug, free target, and drug-target complexes. For mAb with a membrane-bound target, the 4-to-one MM approximation adequately described the data. The 4-to-one QSS approximation converged 8 times faster than the full 4-to-one TMDD.Keywords
All Related Versions
This publication has 16 references indexed in Scilit:
- Avidity in antibody effector functions and biotherapeutic drug designNature Reviews Drug Discovery, 2022
- Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizersNature Communications, 2021
- A bispecific IgG format containing four independent antigen binding sitesScientific Reports, 2020
- Target-mediated drug disposition model for drugs with two binding sites that bind to a target with one binding siteJournal of Pharmacokinetics and Pharmacodynamics, 2017
- IgA as therapeutic antibodyMolecular Immunology, 2015
- Approximations of the target-mediated drug disposition model and identifiability of model parametersJournal of Pharmacokinetics and Pharmacodynamics, 2008
- Monoclonal Antibody Pharmacokinetics and PharmacodynamicsClinical Pharmacology & Therapeutics, 2008
- Pharmacokinetics of Monoclonal Antibodies2006
- Quasi-Equilibrium Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug DispositionPharmaceutical Research, 2005
- General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug DispositionJournal of Pharmacokinetics and Pharmacodynamics, 2001